APOE and Alzheimer disease: However, APOE ε4 carriers and non‐carriers showed approximately opposite aMPFC.R FC trajectories throughout AD progression, especially in the transition from SMC to MCI stages, which might be due to the modulating role of genetic profile in the predementia period.